Drug Shortage Report for METHOTREXATE INJECTION, BP

Last updated on 2025-02-05 History
Report ID 246222
Drug Identification Number 02422166
Brand name METHOTREXATE INJECTION, BP
Common or Proper name METHOTREXATE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 7.5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL
Packaging size 0.3mL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-19
Estimated end date 2025-01-30
Actual end date 2025-02-04
Shortage status Resolved
Updated date 2025-02-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2025-02-05 French Compare
v3 2025-02-05 English Compare
v2 2024-12-20 French Compare
v1 2024-12-20 English Compare

Showing 1 to 4 of 4